Peginterferon Plus Ribavirin for Hepatitis C Patients Concomitant With Malignancy Other Than Hepatocellular Carcinoma

NCT00630084 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Chronic Hepatitis C
Neoplasms

Interventions

DRUG: pegylated interferon alpha 2a and plus ribavirin
DRUG: pegylated interferon alpha 2a and plus ribavirin

Sponsor

Kaohsiung Medical University Chung-Ho Memorial Hospital